Publicaciones de Jorge Federico Elgart

2019

  • Economic Benefit of Sponsored Controlled Clinical Trials: The Avoidable Cost in Drugs for the Treatment of Rheumatoid Arthritis. Liberman, F., Elgart, J., Strusberg, I.(2019) Value in Health Regional Issues, 20, pp. 7-11.DOI: 10.1016/j.vhri.2018.10.007
  • Clinical and Economic Value of p16INK4a for the Differential Diagnosis of Morphologic Cervical Intraepithelial Neoplasia 2. Fishkel, V.S., Monge, F.C., Von Petery, F.M., Tapper, K.E., Peña, T.M., Torres, F., Poletta, F.A., Elgart, J.F., Avagnina, A., Denninghoff, V. (2019) Applied Immunohistochemistry and Molecular Morphology, 27 (9), pp. 672-677. DOI: 10.1097/PAI.0000000000000674
  • Treat-to-target HbA1c and lipid profile to prolong beta-cell mass/function and optimize treatment goal attainment. Gagliardino, J.J., Elgart, J., Forti, L., Guaita, M.S., Chantelot, J.M.(2019) Diabetes/Metabolism Research and Reviews, 35 (6), art. no. e3166,DOI: 10.1002/dmrr.3166
  • Diabetes management and treatment approaches outside of North America and West Europe in 2006 and 2015. Tabesh, M., Magliano, D.J., Tanamas, S.K., Surmont, F., Bahendeka, S., Chiang, C.-E., Elgart, J.F., Gagliardino, J.J., Kalra, S., Krishnamoorthy, S., Luk, A., Maegawa, H., Motala, A.A., Pirie, F., Ramachandran, A., Tayeb, K., Vikulova, O., Wong, J., Shaw, J.E. (2019) Acta Diabetologica, 56 (8), pp. 889-897. DOI: 10.1007/s00592-018-01284-4
  • Type 2 diabetes: Prescription patterns and treatment outcomes of IDMPS survey in Argentina. Gagliardino, J.J., Elgart, J., Forti, L., Ivanna, Q., Chantelot, J.M.(2019) Diabetes Research and Clinical Practice, 153, pp. 86-92. DOI: 10.1016/j.diabres.2019.05.008
  • Cardiovascular disease management in people with diabetes outside North America and Western Europe in 2006 and 2015. Tabesh, M., Magliano, D.J., Tanamas, S.K., Surmont, F., Bahendeka, S., Chiang, C.-E., Elgart, J.F., Gagliardino, J.J., Kalra, S., Krishnamoorthy, S., Luk, A., Maegawa, H., Motala, A.A., Pirie, F., Ramachandran, A., Tayeb, K., Vikulova, O., Wong, J., Shaw, J.E. (2019) Diabetic Medicine, 36 (7), pp. 878-887. DOI: 10.1111/dme.13858
  • Drug treatment of type 2 diabetes: Its cost is significantly associated with HbA1c levels. Elgart, J.F., Silvestrini, C., Prestes, M., Gonzalez, L., Rucci, E., Gagliardino, J.J. (2019) International Journal of Clinical Practice, 73 (4), art. no. e13336. DOI: 10.1111/ijcp.13336

2018

  • Diabetes primary prevention program: New insights from data analysis of recruitment period. Gagliardino JJ, Elgart JF, Bourgeois M, Etchegoyen G, Fantuzzi G, Ré M, Ricart JP, García S, Giampieri C, González L, Suárez-Crivaro F, Kronsbein P, Angelini JM, Martínez C, Martínez J, Ricart A, Spinedi E. Diabetes Metab Res Rev. 2018 Jan;34. doi: 10.1002/dmrr.2943. Epub
  • Diabetes tipo 2: patrones prescriptivos y resultados del tratamiento en IDMPS (International diabetes management practices study) en Argentina. Gagliardino JJ, Elgart JF, Forti L, Querzoli I, De Luca J, Chatelau J. XXI Congreso Argentino de Diabetes, Sociedad Argentina de Diabetes (SAD). Revista de la SAD. 2018; 52:81.
  • Tratamiento farmacológico de la diabetes tipo 2: su costo está significativamente asociado con los niveles de HbA1c. Elgart JF, Silvestrini C, Prestes M, Gonzalez L, Rucci E, Gagliardino JJ. XXI Congreso Argentino de Diabetes, Sociedad Argentina de Diabetes (SAD). Revista de la SAD. 2018; 52:95-96.
  • Ingesta alimentaria en la población adulta de dos ciudades de la Provincia de Buenos Aires: su adecuación a las recomendaciones nutricionales. García S, Fantuzzi G, Angelini JM, Bourgeois M, Elgart JF, Etchegoyen G, Giampieri C, González L, Kronsbein P, Martínez C, Martínez J, Prestes M, Ré M, Ricart A, Ricart JP, Gagliardino JJ. Actualización en Nutrición. 2018 Jun; 19(2): 38-43. (ISSN 1667-8052).

2017

  • Relation between cost of drug treatment and body mass index in people with type 2 diabetes in Latin America. Elgart JF, Prestes M, Gonzalez L, Rucci E, Gagliardino JJ; QUALIDIAB Net study group. PLoS One. 2017 Dec 20;12(12):e0189755. doi: 10.1371/journal.pone.0189755.
  • Health inequalities and the impact on the prevalence of cardiovascular risk factors and chronic complications in Argentina: a study on national risk factors surveys. Asteazaran S, Gagliardino JJ, Elgart JF. Medwave. 2017 Nov 27;17(9):e7083. doi:10.5867/medwave.2017.09.7083.
  • Improving diabetes care at primary care level with a multistrategic approach: results of the DIAPREM programme. Prestes M, Gayarre MA, Elgart JF, Gonzalez L, Rucci E, Paganini JM, Gagliardino JJ; DIAPREM (DIAbetes Primary Care, Registry, Education and Management). Acta Diabetol. 2017 Jun 17. doi: 10.1007/s00592-017-1016-8.
  • Multistrategic approach to improve quality of care of people with diabetes at the primary care level: Study design and baseline data. Prestes M, Gayarre MA, Elgart JF, Gonzalez L, Rucci E, Gagliardino JJ; DIAPREM (DIAbetes Primary Care, Registry, Education and Management). Prim Care Diabetes. 2017 Apr;11(2):193-200.
  • Evolución de la Calidad de Atención en personas con Diabetes Tipo 2 (DMT2) de Argentina: Resultados del International Diabetes Management Practices Study (IDMPS). Elgart JF, Forti L, De Luca J, Guaita MS, Gagliardino JJ. ISPOR 6th Latin America Conference (Sao Pablo, Brasil). Value in Health, 2017; 20(9):A921–A922.
  • Costo Medico Directo Atribuible al tratamiento de pacientes con Neoplasia Intraepitelial Cervical (CIN) 2 Morfológico e impacto económico del diagnóstico diferencial con Biomarcador P16 en una Institución Privada de la Ciudad De Buenos Aires. Elgart JF, Fishkel V, von Petery F, Peña T, Torres F, Avagnina A, Monge F, Denninghoff V. ISPOR 6th Latin America Conference (Sao Pablo, Brasil). Value in Health, 2017; 20(9):A924.
  • Resultados de la Implementación de una estrategia combinada de Educación y Gestión de Pacientes en Centros de Atención Primaria de Argentina. Prestes M, Gayarre MA, Elgart JF, Rucci E, Paganini JM, Gagliardino JJ. ISPOR 6th Latin America Conference (Sao Pablo, Brasil). Value in Health, 2017; 20(9):A857–A858.
  • Clinical-metabolic characteristics of people with Type 2 Diabetes in Argentina: Results from the 2006-2012 International Survey of Diabetes Management Practices (IDMPS). Gagliardino JJ, Elgart J, Forti L, Guaita S, De Luca J. 4th Latin America CODHy Congress. Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy). 2017.
  • International Diabetes Management Practice Survey (IDMPS): Determinants for achieving therapeutic goals in people with Type 2 Diabetes in Argentina. Gagliardino JJ, Elgart J, Forti L, Guaita S, De Luca J. 4th Latin America CODHy Congress. Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy). 2017.